Lynwood Capital Management Inc. - PHOENIX BIOTECH ACQUISITION ownership

Back to all holdings Add to watchlist

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 55 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2022$613
-99.8%
59,615
+50.5%
0.74%
+68.6%
Q3 2022$400,000
+15.3%
39,615
+14.4%
0.44%
+12.6%
Q2 2022$347,000
+17.2%
34,615
+16.9%
0.39%
+22.0%
Q1 2022$296,000–29,615–0.32%–
 Download
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders